Equifax (EFX)
NYSEIndustrialsConsulting ServicesSnapshot 2026-09-04
$177.05-6.37%
Close 2026-09-04 · 1-day change
NYSEIndustrialsConsulting ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · EFX
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How this business ranks within industrials on a research-validated quality screen. As of 2026-09-04.
The screen ranks EFX against its sector on four durable signals: share dilution, return on capital, free-cash-flow yield, and FCF margin. Historically the highest-quality names tended toward better typical outcomes and fewer bad years over multi-year holds (strongest at three years, modest at one), and that pattern showed up even before the price moved. It characterizes business quality, not price direction.
Each leg is a sector-relative percentile (higher is better); 4 of 4 legs were available for this name. The composite is built from these four; the raw value follows each percentile for context.
A forward quality tilt, not a price prediction, and context for your own research rather than a recommendation. Not investment advice.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 3 of the last 3 quarter-over-quarter moves. Historically, Industrials names rated strong grew net income 67% of the time over the next year (vs 52% for the rest of the cohort, n=6958).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Met or beat guidance 100% of the last 8 guided quarters · 10.6% avg surprise
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Focus on accelerating new product innovation leveraging EFX Cloud, EFX.AI, and proprietary data to achieve and sustain double-digit revenue growth and a high new product Vitality Index.
Stated as a priority in 7 of last 7 quarters. New product Vitality Index was 13% in 2024-Q3, rose to 17% in 2026-Q1, and was 16% in 2026-Q2, consistently above the 10% long-term goal. Management is delivering sustained double-digit innovation-driven revenue growth.
“New Product Innovation leveraging the EFX Cloud, EFX.AI, and proprietary data delivered strong 16% new product Vitality Index.”
“New Product Innovation leveraging the EFX Cloud, EFX.AI, and proprietary data delivered record level 17% new product Vitality Index.”
“Record fourth quarter Vitality Index of 17%, above our 10% long-term goal, leveraging new EFX Cloud and EFX.AI.”
“Raising full year 2025 Vitality Index to 13%, above our 10% long-term goal, from strong 16% Vitality in the quarter leveraging new EFX Cloud and EFX.AI.”
“New Product Innovation leveraging new EFX Cloud and EFX.AI delivered 14% new product Vitality Index, above our 10% LT Goal.”
“New Product Innovation leveraging new EFX Cloud delivered 11% new product Vitality Index, above our 10% LT Goal.”
“Strong new product innovation leveraging new EFX Cloud with 13% new product Vitality Index.”
Sustain reported and local currency revenue growth around 10% annually, supported by diversified markets and strong U.S. mortgage revenue growth.
Stated as a priority in 7 of last 7 quarters. Revenue grew from $1.419 billion in 2024-Q4 to $1.700 billion in 2026-Q2, an 11% increase in reported terms with 10% local currency growth. Full year 2026 revenue guidance remains at $6.71-$6.78 billion, consistent with management's growth targets, indicating delivery on stated revenue growth priorities.
Continue returning significant cash to shareholders through share repurchases and dividend increases, supported by strong free cash flow generation.
Stated as a priority in 6 of last 6 quarters. Equifax returned $366 million in cash to shareholders in 2026-Q2, including $300 million in share repurchases and $66 million in dividends. The Board authorized a $3 billion share repurchase program in 2025-Q1. The company is delivering consistent capital returns aligned with stated priorities.
Grow international revenue with emphasis on Latin America and Asia Pacific regions, achieving mid to high single-digit local currency growth.
Stated as a priority in 5 of last 5 quarters. International revenue grew from $344.9 million in 2024-Q3 to $383.1 million in 2026-Q2, an 11% increase reported and 4% local currency growth in 2026-Q2. Latin America and Asia Pacific showed strong reported growth of 9% and 17% respectively in 2026-Q2. Management is delivering consistent international growth.
Deploy AI technologies to accelerate cost reduction initiatives, doubling the AI-driven cost reduction target to $150 million from 2026 to 2028.
Newly stated in 2026-Q1 and reiterated in 2026-Q2. Management doubled the AI-driven cost reduction target to $150 million for 2026-2028, reflecting accelerating deployment of AI across operations. While financial impact is forward-looking, management is emphasizing AI as a key operational efficiency driver.
“Doubling 2026-2028 AI-driven cost reduction target to $150 million.”
Over the trailing year it converted 1.85x of net income into operating cash flow. Historically, Industrials names rated robust grew net income 58% of the time over the next year (vs 54% for the rest of the cohort, n=4997).
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, long-term interest rates, Fed net liquidity (low R² over the window).
5 material management or governance events in the past 24 months, led by capital-allocation actions. Historically, Industrials names rated stable grew net income 55% of the time over the next year (vs 58% for the rest of the cohort, n=2546).
Not investment advice. As of 2026-09-04.
“Second quarter reported revenue of $1.700 billion, up 11% with 10% local currency revenue growth.”
“First quarter reported revenue of $1.649 billion, up 14% with 13% local currency revenue growth.”
“Fourth quarter 2025 revenue of $1.551 billion up 9% and $30 million above the midpoint of guidance.”
“Third quarter 2025 revenue of $1.545 billion up 7% and $25 million above the midpoint of Guidance.”
“Second quarter 2025 revenue of $1.537 billion up 7% reported and 8% in local currency.”
“First quarter 2025 revenue of $1.442 billion up 4% with 5% local currency revenue growth.”
“Fourth quarter 2024 revenue of $1.419 billion up 7%, with 9% local currency revenue growth.”
“Returned $366 million in cash to shareholders including repurchasing 1.8 million shares for $300 million and paying $66 million in quarterly dividends.”
“Returned $327 million in cash to shareholders including repurchasing 1.3 million shares for $260 million and paying $67 million in quarterly dividends.”
“Returned $561 million of cash to shareholders including repurchasing 2.3 million shares for $500 million.”
“Returned approximately $360 million of cash to shareholders including repurchasing 1.2 million shares for $300 million.”
“Returned approximately $190 million of cash to shareholders including $127 million of share repurchases.”
“Board authorized $3 billion share repurchase program and increased dividend by 28% to $0.50 per share.”
“International second quarter revenue up 8% on a reported basis and 4% on a local currency basis.”
“International first quarter revenue up 11% on a reported basis with 4% growth on a local currency basis.”
“International fourth quarter revenue up 7% on a reported basis with 5% growth on a local currency basis.”
“International third quarter revenue up 6% on a reported basis with 7% growth on a local currency basis.”
“International second quarter revenue up 4% on a reported basis with 6% on a local currency basis.”
“We are doubling our AI-driven cost reduction goal set earlier in the year to $150 million from 2026 to 2028.”